Syneos Health Reports First Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
UPDATE: Syneos Health (SYNH) Tops Q1 EPS by 6c, Offers FY Guidance
April 29, 2022 6:39 AM EDT(Updated - April 29, 2022 6:40 AM EDT)
Syneos Health (NASDAQ: SYNH) reported Q1 EPS of $1.01, $0.06 better than the analyst estimate of $0.95. Revenue for the quarter came in at $1.34 billion versus the consensus estimate of $1.32 billion.
GUIDANCE:
Syneos Health sees... More
